Tarsus Pharmaceuticals clinical trials we track

Check company identity source

Phase 3 1 trial

TrialDrugs studiedStatusPrimary completion
Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex BlepharitisNCT04784091TP-03, TP-03 VehicleCompleted2022-05-09Actual

Phase 2 / 3 1 trial

TrialDrugs studiedStatusPrimary completion
Safety and Efficacy of TP-03 for the Treatment of Demodex BlepharitisNCT04475432TP-03 Vehicle, TP-03, 0.25%Completed2021-05-04Actual

Phase 2 7 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 700 participants (planned). After: 722 participants (actual).

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source